PET-CT is widely recommended in international clinical guidelines, including those of the European Association of Nuclear ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of ...

Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image ...

A macrophage-targeted PET/CT tracer predicts anti-TNF response in rheumatoid arthritis at baseline and four weeks, enabling ...

MedGenome to acquire a majority stake in Medcare Management Services, expanding its western India footprint and creating a ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

MedGenome has announced a majority investment in Mumbai-headquartered Medcare Management Services, a radiology and nuclear medicine provider specialising in PET-CT and molecular imaging services.

MedGenome invests in Medcare Diagnostics to enhance integrated diagnostic services across western India, focusing on advanced imaging and genomics.

MedGenome makes a majority investment in Medcare Diagnostics to expand offerings across western India: Our Bureau, Bengaluru Monday, March 2, 2026, 16:15 Hrs [IST] MedGenome, Indi ...

With more than three decades of experience supporting tens of thousands of clinical scans nationwide, Positron continues to position itself as a trusted partner to nuclear cardiology practices seeking ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four ...